<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2260">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05131737</url>
  </required_header>
  <id_info>
    <org_study_id>OVERALP II C</org_study_id>
    <nct_id>NCT05131737</nct_id>
  </id_info>
  <brief_title>Exercise Endurance Time on the 2nd Day at 2500 m High Altitude</brief_title>
  <official_title>The Impact of Hypoxia on Patients With Precapillary Pulmonary Hypertension and Treatment of Adverse Effects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The impact of a sojourn at 2500 m of high altitude for 26-30 h on constant work-rate exercise&#xD;
      test time in patients with precapillary pulmonary hypertension&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with pulmonary hypertension will perform a constant work-rate exercise test at low&#xD;
      altitude (450m) and at high altitude 2500m in a randomized-cross-over sequence protocol. The&#xD;
      constant work-rate exercise test time and other measures will be assessed&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 18, 2021</start_date>
  <completion_date type="Anticipated">January 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">January 16, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>cycle constant work-rate exercise test</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in cycle constant work-rate exercise test (CWRET) time at 2500 vs. 490 m (Time Frame 24 to 30 hours)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Heart rate</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in cardiorespiratory measurements: Heart rate, during a cycle constant work-rate exercise test (CWRET) time at high altitude vs. low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ventilation in liters per minute</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in cardiorespiratory measurements: Ventilation assessed in liters per minute, during a cycle constant work-rate exercise test (CWRET) time at high altitude vs. low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen uptake</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in cardiorespiratory measurements: oxygen uptake, during a cycle constant work-rate exercise test (CWRET) time at high altitude vs. low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxygen saturation</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in cardiorespiratory measurements: Oxygen saturation, during a cycle constant work-rate exercise test (CWRET) time at high altitude vs. low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Partial pressure or oxygen</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in partial pressure of oxygen at the beginning and end of a cycle constant work-rate exercise test (CWRET) time at high altitude vs. low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tricuspid pressure gradient</measure>
    <time_frame>30 hours</time_frame>
    <description>Trans-tricuspid pressure gradient by echocardiography</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Borg dyspnoea scale</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in post-exercise Borg dyspnoea and leg fatigue scale during a cycle constant work-rate exercise test (CWRET) time at high altitude vs. low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual analogue scale</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in baseline in symptoms assessed by the Visual Analogue Scale at high altitude vs. low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sit-to-stand test frequency</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in baseline in sit-to-stand test frequency of standing up from a chair in a minute at high altitude vs. low altitude</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>6 minute walk test</measure>
    <time_frame>30 hours</time_frame>
    <description>Difference in baseline in 6 minute walk test distance at high altitude vs. low altitude</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">24</enrollment>
  <condition>High Altitude Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>Constant work-rate at altitude 2500 m above sea level (high altitude)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Cycling at high altitude</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Constant work-rate at altitude 470 m above sea level (low altitude)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Cycling at low altitude</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>High altitude exposure</intervention_name>
    <description>Exposure to 2500m of altitude</description>
    <arm_group_label>Constant work-rate at altitude 2500 m above sea level (high altitude)</arm_group_label>
    <arm_group_label>Constant work-rate at altitude 470 m above sea level (low altitude)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Low altitude exposure</intervention_name>
    <description>Exposure to 490 m</description>
    <arm_group_label>Constant work-rate at altitude 2500 m above sea level (high altitude)</arm_group_label>
    <arm_group_label>Constant work-rate at altitude 470 m above sea level (low altitude)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Informed consent as documented by signature&#xD;
&#xD;
          -  PH class I (PAH) or IV (CTEPH) diagnosed according to guidelines: mean pulmonary&#xD;
             artery pressure &gt;20 mmHg, pulmonary vascular resistance ≥3 wood units, pulmonary&#xD;
             arterial wedge pressure ≤15 mmHg during baseline measures at the diagnostic&#xD;
             right-heart catheterization&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  resting partial pressure of oxygen &lt;8 kilopascal at Zurich at 490 m low altitude&#xD;
&#xD;
          -  exposure to an altitude &gt;1000 m for ≥3 nights during the last 2 weeks before the study&#xD;
&#xD;
          -  inability to follow the procedures of the study&#xD;
&#xD;
          -  other clinically significant concomitant end-stage disease (e.g., renal failure,&#xD;
             hepatic dysfunction)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Silvia o Ulrich, Prof. Dr.</last_name>
    <phone>+41442552220</phone>
    <email>silvia.ulrich@usz.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Simon Schnieder, MA</last_name>
    <phone>+41442552220</phone>
    <email>simonrafael.schneider@usz.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital of Zurich</name>
      <address>
        <city>Zurich</city>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Silvia Ulrich, Prof. Dr.</last_name>
      <phone>+41442552220</phone>
      <email>silvia.ulrich@usz.ch</email>
    </contact>
    <contact_backup>
      <last_name>Simon Schnieder, MA</last_name>
      <phone>+41442552220</phone>
      <email>simonrafael.schneider@usz.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 14, 2021</study_first_submitted>
  <study_first_submitted_qc>November 11, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 23, 2021</study_first_posted>
  <last_update_submitted>November 11, 2021</last_update_submitted>
  <last_update_submitted_qc>November 11, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

